-
Product Insights
New![]()
Likelihood of Approval Analysis for Papillary Thyroid Cancer
Overview How likely is it that the drugs in Papillary Thyroid Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Papillary Thyroid Cancer Overview Papillary thyroid cancer (PTC) is the most...
-
Company Profile
![]()
Veracyte Inc – Company Profile
Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also provides percepta bronchial genomic classifier as an assay to evaluate patients with lung nodules that are suspected of cancer. Veracyte offers genomic testing to other areas of substantial clinical need with diagnostic ambiguity. The company markets its afirma solutions...
Add to Basket -
Product Insights
New![]()
Veracyte Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Veracyte Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products comprise Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also provides percepta bronchial genomic classifier as an assay to evaluate patients with lung nodules that are suspected of cancer....
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.